MyAverix Finance
NS · Healthcare
Gennex Laboratories Ltd (531739)
Pharmaceuticals & Biotechnology
Gennex Laboratories Ltd (531739) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.61B, P/E ratio is 16.18, net margin is 14.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 531739
Gennex Laboratories Ltd (531739) — FAQ
What is Gennex Laboratories Ltd's market cap?
Gennex Laboratories Ltd (531739) has a reported market cap of $2.61B (data as of 2026-07-10).
What is 531739's P/E ratio?
The price-to-earnings (P/E) ratio for Gennex Laboratories Ltd (531739) is 16.18 (data as of 2026-07-10).
Does Gennex Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Gennex Laboratories Ltd (531739). Check the MyAverix Finance app for the latest dividend data.
What sector is Gennex Laboratories Ltd in?
Gennex Laboratories Ltd (531739) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 531739 listed on?
531739 is listed on NS.
What is Gennex Laboratories Ltd's net margin?
Gennex Laboratories Ltd (531739) reports a net margin of 14.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.